4.5 Article

Pathogenic SCN2A variants cause early-stage dysfunction in patient-derived neurons

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Cellular and behavioral effects of altered NaV1.2 sodium channel ion permeability in Scn2aK1422E mice

Dennis M. Echevarria-Cooper et al.

Summary: Genetic variants in the SCN2A gene are associated with neurodevelopmental disorders. However, the classification framework may not fully explain the effects of certain variants, such as SCN2A-p.K1422E, which is linked to developmental delay, spasms, and ASD. Research on a mouse model showed that the K1422E variant has complex effects on the Na(V)1.2 channel function, leading to phenotypes similar yet distinct from other models.

HUMAN MOLECULAR GENETICS (2022)

Article Neurosciences

SCN2A-related epilepsy of infancy with migrating focal seizures: report of a variant with apparent gain- and loss-of-function effects

Xiao-Ru Yang et al.

Summary: Pathogenic variants in the SCN2A gene are associated with epilepsy and neurodevelopmental disorders. However, the true electrophysiological effects of most disease-causing variants have yet to be characterized. In this study, a mosaic variant in the SCN2A gene was found in an infant with early-onset epilepsy, and biophysical characterization revealed a mixture of gain- and loss-of-function effects.

JOURNAL OF NEUROPHYSIOLOGY (2022)

Article Neurosciences

Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant

Zhefu Que et al.

Summary: The study reveals that the SCN2A gene variant L1342P can increase intrinsic excitability of neurons, leading to hyperexcitability phenotypes. Neuronal cultures carrying this variant exhibit some resistance to anticonvulsant medication but can be alleviated by a specific blocker, phrixotoxin-3 (PTx3), suggesting potential therapeutic interventions for patients with this genetic variant.

JOURNAL OF NEUROSCIENCE (2021)

Review Neurosciences

Sodium channelopathies in neurodevelopmental disorders

Miriam H. Meisler et al.

Summary: This review explores the neurological disorders associated with mutations in SCN1A, SCN2A, and SCN8A genes and the therapeutic opportunities arising from recent mechanistic insights. It summarizes the basic elements of sodium channel function used to characterize patient variants and provides examples of the effects of patient mutations on channel function. The review also highlights emerging therapeutic interventions based on new insights into mechanisms of sodium channelopathies.

NATURE REVIEWS NEUROSCIENCE (2021)

Article Cell Biology

Paradoxical hyperexcitability from NaV1.2 sodium channel loss in neocortical pyramidal cells

Perry W. E. Spratt et al.

Summary: The loss of Na(V)1.2 channels in pyramidal neurons leads to intrinsically hyperexcitable neurons, firing high-frequency bursts of action potentials despite reductions in AP size and speed. This cell-intrinsic mechanism may explain why loss-of-function variants in SCN2A gene paradoxically promote seizure.

CELL REPORTS (2021)

Article Cell Biology

Severe deficiency of the voltage-gated sodium channel NaV1.2 elevates neuronal excitability in adult mice

Jingliang Zhang et al.

Summary: Severe Na(V)1.2 deficiency unexpectedly results in increased neuronal excitability, which can be reversed by genetic restoration. This neuronal hyperexcitability may serve as a cellular basis underlying Na(V)1.2 deficiency-related seizures.

CELL REPORTS (2021)

Article Genetics & Heredity

Developmental dynamics of voltage-gated sodium channel isoform expression in the human and mouse brain

Lindsay Liang et al.

Summary: Genetic variants in SCN1A, SCN2A, SCN3A, and SCN8A voltage-gated sodium channels are leading causes of epilepsy, developmental delay, and autism spectrum disorder. The expression of individual exons in these genes changes dramatically during human brain development, potentially accounting for observed differences in phenotypes. Manipulation of splicing isoform proportions at appropriate stages may offer therapeutic strategies for specific mutations or epilepsy in general.

GENOME MEDICINE (2021)

Article Medicine, Research & Experimental

Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model

Melody Li et al.

Summary: De novo variation in SCN2A can result in severe childhood disorders, and targeted reduction in SCN2A expression may substantially improve clinical outcomes. In a mouse model, administration of ASO treatment can reduce spontaneous seizures and extend lifespan, with good treatment tolerability, potentially impacting the lives of patients with SCN2A gain-of-function DEE.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Genetics & Heredity

Elucidation of the phenotypic spectrum and genetic landscape in primary and secondary microcephaly

Paranchai Boonsawat et al.

GENETICS IN MEDICINE (2019)

Article Biochemistry & Molecular Biology

Comprehensive Integration of Single-Cell Data

Tim Stuart et al.

Article Multidisciplinary Sciences

NaV1.2 haploinsufficiency in Scn2a knock-out mice causes an autistic-like phenotype attenuated with age

Isabelle Lena et al.

SCIENTIFIC REPORTS (2019)

Review Neurosciences

Mitochondria as central regulators of neural stem cell fate and cognitive function

Mireille Khacho et al.

NATURE REVIEWS NEUROSCIENCE (2019)

Article Genetics & Heredity

De Novo and Inherited Pathogenic Variants in KDM3B Cause Intellectual Disability, Short Stature, and Facial Dysmorphism

Illja J. Diets et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2019)

Review Neurosciences

Progress in Understanding and Treating SCN2A-Mediated Disorders

Stephan J. Sanders et al.

TRENDS IN NEUROSCIENCES (2018)

Article Biology

Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice

Ikuo Ogiwara et al.

COMMUNICATIONS BIOLOGY (2018)

Article Multidisciplinary Sciences

Prevalence and architecture of de novo mutations in developmental disorders

Jeremy F. McRae et al.

NATURE (2017)

Article Endocrinology & Metabolism

Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?

Gabriella A. Horvath et al.

MOLECULAR GENETICS AND METABOLISM (2016)

Article Biochemistry & Molecular Biology

'Neonatal' Nav1.2 reduces neuronal excitability and affects seizure susceptibility and behaviour

Elena V. Gazina et al.

HUMAN MOLECULAR GENETICS (2015)

Article Biochemical Research Methods

Causal analysis approaches in Ingenuity Pathway Analysis

Andreas Kraemer et al.

BIOINFORMATICS (2014)

Article Biochemistry & Molecular Biology

Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients neurons

Steven Havlicek et al.

HUMAN MOLECULAR GENETICS (2014)

Article Neurosciences

Fast Sodium Channel Gating Supports Localized and Efficient Axonal Action Potential Initiation

Christoph Schmidt-Hieber et al.

JOURNAL OF NEUROSCIENCE (2010)

Review Neurosciences

Mechanisms underlying spontaneous patterned activity in developing neural circuits

Aaron G. Blankenship et al.

NATURE REVIEWS NEUROSCIENCE (2010)

Article Clinical Neurology

Scn2a sodium channel mutation results in hyperexcitability in the hippocampus in vitro

Kara Buehrer Kile et al.

EPILEPSIA (2008)

Review Multidisciplinary Sciences

Electrical activity in early neuronal development

Nicholas C. Spitzer

NATURE (2006)